EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Tablet‐Assisted Speech and Language Therapy for Acute Post‐Stroke Aphasia: A Randomized Clinical Trial ( LEXI Study)

Johannes Wischmann iD, Leanna Brasch, Julia Franzen, Jennifer Schwierz, Oksana Kovalenko, Andrea Gutmann, Franziska Erbert, Luisa Bußmann, Julia Lauer, Claudia Dumberger, Alexander Mandl, Marie Mehringer und 17 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.70443 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Johannes Wischmann und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, LMU University Hospital Munich, Munich, Germany. Hauptthemen laut MEDLINE: Aphasia, Stroke, Language Therapy, Speech Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aphasia after acute stroke is a frequent and disabling condition, impairing communication and quality of life. We investigated whether tablet‐assisted Speech and Language Therapy ( SLT ) using the Neolexon application is superior to standard SLT in acute stroke patients.

Methods

In this prospective, open‐label, randomized, controlled clinical trial, patients with acute post‐stroke aphasia were recruited from one stroke center and two neurorehabilitation clinics in Germany. Participants were stratified by aphasia severity and randomized to tablet‐assisted SLT ( n = 53) or standard SLT ( n = 51), initiated during inpatient care and continued in rehabilitation (30 min/Day). The primary outcome was the change in the Bielefelder Aphasia Screening ( BIAS ) percentile rank from baseline to 90 days. Secondary outcomes included frequency and duration of self‐training.

Results

From 07/2021 to 09/2024, 4097 patients were screened and 104 randomized (mean age 74.4 ± 11.2 years; 51.9% female). No significant difference in BIAS change was found at 90 days (18 vs. 14). The trial was stopped early for futility. The intervention group engaged in self‐directed training more frequently (37.7% vs. 21.6%) and trained longer (10 vs. 4 h). Subgroup analyses showed benefits of tablet‐assisted SLT in patients with mild ( β = 15.51; 95% CI −1.67 to 32.69) and moderate aphasia ( β = 23.58; 95% CI −4.48 to 51.65), and those with a National Institutes of Health Stroke Scale of less than 5 ( β = 21.69; 95% CI 5.54–37.84).

Conclusions

Although underpowered to demonstrate overall superiority, tablet‐assisted SLT showed potential benefits in patients with mild to moderate aphasia and less severe strokes in the acute setting. Trial Registration: ClinicalTrials.gov Identifier: NCT04080817

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AphasiaStrokeLanguage TherapySpeech TherapyStroke RehabilitationComputers, HandheldHumansFemaleMaleAgedMiddle AgedAged, 80 and overProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

acute strokeaphasiacomputerized therapyneurorehabilitationrandomized controlled trialspeech and language therapy

Autor:innen und Institutionen

  • Department of Neurology, LMU University Hospital Munich, Munich, Germany.
  • Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany.
  • Department of Anaesthesiology, LMU University Hospital, Munich, Germany.
  • Department of Orthopedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), LMU University Hospital Munich, Munich, Germany.
  • Institute for Social Sciences and Humanities, Ostbayerische Technische Hochschule OTH, Regensburg, Germany.
  • Clinic for Neurology, Medical Park, Reithof Park, Bad Feilnbach, Germany.

ORCID-Profile: Johannes Wischmann, Katharina Feil, Lars Kellert

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Wischmann, J., Brasch, L., Franzen, J., Schwierz, J., Kovalenko, O., Gutmann, A., Erbert, F., Bußmann, L., Lauer, J., Dumberger, C., Mandl, A., Mehringer, M., Münsterer, A., Spitzer, J., Winterhalter, L., Frank, V., Rheinwald, M., Lehner, K., Ammer, F., …, & Kellert, L. (2025). Tablet‐Assisted Speech and Language Therapy for Acute Post‐Stroke Aphasia: A Randomized Clinical Trial ( LEXI Study). European Journal of Neurology. https://doi.org/10.1111/ene.70443

Vancouver

Wischmann J, Brasch L, Franzen J, Schwierz J, Kovalenko O, Gutmann A, et al. Tablet‐Assisted Speech and Language Therapy for Acute Post‐Stroke Aphasia: A Randomized Clinical Trial ( LEXI Study). European Journal of Neurology. 2025. doi:10.1111/ene.70443

BibTeX
@article{Wischmann2025,
  author = {Wischmann, Johannes and Brasch, Leanna and Franzen, Julia and Schwierz, Jennifer and Kovalenko, Oksana and Gutmann, Andrea and Erbert, Franziska and Bußmann, Luisa and Lauer, Julia and Dumberger, Claudia and Mandl, Alexander and Mehringer, Marie and Münsterer, Annette and Spitzer, Julia and Winterhalter, Lena and Frank, Vanessa and Rheinwald, Marika and Lehner, Katharina and Ammer, Franziska and Pfahler, Angelika and Lampart, Stefanie and Young, Charlotte and Young, Peter and Goettert, Barbara and Bitzan, Marcella and Rinder, Stephanie and Meier, Oliver and Feil, Katharina and Kellert, Lars},
  title = {Tablet‐Assisted Speech and Language Therapy for Acute Post‐Stroke Aphasia: A Randomized Clinical Trial ( LEXI Study)},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70443}
}
Kostenlos starten →